ATLANTA--(BUSINESS WIRE)--AmeritoxSM, the nation’s leader in medication monitoring solutions, and PRIUM, a medical intervention company focused on reducing opioid misuse in workers’ compensation, today announced their medical and business team leaders will lead a panel discussion at the upcoming 2014 National Rx Drug Abuse Summit. The summit brings together stakeholders from government agencies and the education and healthcare fields to identify ways to combat prescription drug abuse.
PRIUM Senior Vice President Mark Pew will moderate “The 411 on a Successful Rx Drug Weaning Program.” Joining him are Ameritox Vice President of Medical Affairs Kathryn Bronstein, PhD, RN and Krista Jordan, PhD with Restore Rx. Dr. Bronstein directs a team of field-based scientists responsible for providing clinical education on medication monitoring, and Dr. Jordan developed and runs an interdisciplinary functional restoration program.
“Weaning is not just chemical detox,” Pew said. “Medical-pharmacological, psychological and physical fitness treatment work together to enable patients to truly overcome their dependence on drugs,” Pew said.
The discussion will begin at 1:30 on April 23. The National Rx Drug Abuse Summit takes place April 22 through 24 at the Atlanta Marriott Marquis.
An Ameritox solutions provider, PRIUM sets the industry standard for workers’ compensation medical interventions through its ability to secure higher agreement rates and to help ensure compliance with modified treatment plans. The hallmark of the medical intervention company’s success is a collaborative physician engagement process encompassing evidence-based medicine, clinical oversight, and jurisdictional guidelines to facilitate optimal financial and clinical outcomes. PRIUM helps eliminate unnecessary treatment through a comprehensive approach that includes complex medical interventions, utilization reviews, urine drug monitoring, and independent medical exams. Based in Duluth, Ga., PRIUM can be reached at prium.com or 888.588.4964.
Ameritox helped pioneer the prescription drug monitoring necessary to address the national epidemic of prescription drug misuse, abuse, and diversion. As the nation’s trusted leader in Pain Medication Monitoring SolutionsSM, Ameritox provides medical and business professionals with data-driven analysis and tailored solutions that can improve patient care and prevent tragedy. Ameritox, headquartered in Baltimore, Md., has 800 employees nationwide and laboratory facilities in Greensboro, N.C.